Systematic review of clinical trials and cohort studies evaluating HIV post-exposure prophylaxis (PEP) regimens to inform updated Canadian guidelines. (PubMed, Br J Clin Pharmacol) - Oct 17, 2026 - "Multiple PEP regimens have been associated with high completion, good tolerability and rare seroconversion, supporting their inclusion in clinical guidelines."
Journal • Human Immunodeficiency Virus • Infectious Disease
|
|
Ameeta E Singh; Darrell H S Tan; Deborah Yoong; Jaris Swidrovich; Jean-Guy Baril; Jessie Tu; Mark W Hull; Maryam Habib; Patrick O'Byrne; Rija Khalid; Stanley O Onyegbule; Tatiana Sotindjo; Wale Ajiboye
|